An exploration of how targeted nanoparticles and artificial intelligence algorithms combine to locate prostate cancer earlier ...

MRI-guided transurethral ultrasound ablation associated with less blood loss, shorter stays, and less pain than robotic prostatectomy.

Prostate cancer remains one of the most common diseases among men, yet current screening methods often lead to unnecessary ...

Microbot Medical MBOT recently announced the successful completion of the limited market release of its LIBERTY Endovascular ...

Microbot Medical (Nasdaq:MBOT) today announced the full market release of its Liberty endovascular surgical robot in the U.S.

Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative LIBERTY® Endovascular Robotic System, announced today that it has successfully executed its limited market release ...

Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative LIBERTY® Endovascular Robotic System, announced today that it has successfully executed ...

Microbot Medical Inc. announced that it has executed a limited market release of the Liberty robotic system for peripheral ...

I am a 72-year-old male who was diagnosed with Type 2 diabetes about 30 years ago. I’ve been insulin-dependent for about 20 ...

Laguna Hills, Calif.-based Orange County Urology Associates has partnered with IR Centers and Prostate Centers USA to develop an outpatient interventional radiology program.  The program will ...

Embolization, Inc. announced findings from the limited-market release of the company’s nitinol enhanced device (NED), which ...

TORONTO, March 27, 2026 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) ("Profound" or the "Company"), a commercial-stage medical device company that develops and markets AI-powered, ...